Literature DB >> 25024598

Nonalcoholic fatty liver disease and cardiovascular disease.

Hong Liu1, Hong-Yun Lu1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are two diseases that are common in the general population. To date, many studies have been conducted and demonstrate a direct link between NAFLD and CVD, but the exact mechanisms for this complex relationship are not well established. A systematic search of the PubMed database revealed that several common mechanisms are involved in many of the local and systemic manifestations of NAFLD and lead to an increased cardiovascular risk. The possible mechanisms linking NAFLD and CVD include inflammation, oxidative stress, insulin resistance, ectopic adipose tissue distribution, dyslipidemia, endothelial dysfunction, and adiponectin, among others. The clinical implication is that patients with NAFLD are at an increased risk of CVD and should undergo periodic cardiovascular risk assessment.

Entities:  

Keywords:  Cardiovascular disease; Metabolic syndrome; Nonalcoholic fatty liver disease; Risk assessment

Mesh:

Year:  2014        PMID: 25024598      PMCID: PMC4093693          DOI: 10.3748/wjg.v20.i26.8407

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  77 in total

1.  No association between the degree of liver steatosis and early signs of vasculopathy in T2DM.

Authors:  A Coracina; S Gaiani; A Cosma; P Pellizzari; C Pizzi; S de Kreutzenberg; D Cecchet; D Sacerdoti; P Tessari
Journal:  Nutr Metab Cardiovasc Dis       Date:  2012-03-05       Impact factor: 4.222

2.  Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease.

Authors:  Samer Gawrieh; Tesfaye M Baye; Melanie Carless; James Wallace; Richard Komorowski; David E Kleiner; Deborah Andris; Bassem Makladi; Regina Cole; Michael Charlton; Joanne Curran; Thomas D Dyer; Jac Charlesworth; Russell Wilke; John Blangero; Ahmed H Kissebah; Michael Olivier
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

3.  Fragmentation reactions of methionine-containing protonated octapeptides and fragment ions therefrom: an energy-resolved study.

Authors:  Alex G Harrison
Journal:  J Am Soc Mass Spectrom       Date:  2013-08-14       Impact factor: 3.109

4.  Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk.

Authors:  Chia-Chi Wang; Tai-Chung Tseng; Tsung-Cheng Hsieh; Ching-Sheng Hsu; Pin-Chao Wang; Hans Hsienhong Lin; Jia-Horng Kao
Journal:  Kaohsiung J Med Sci       Date:  2012-01-17       Impact factor: 2.744

5.  Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.

Authors:  Maria Stepanova; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-13       Impact factor: 11.382

6.  [Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease].

Authors:  M M Severova; E A Saginova; M G Galliamov; N V Ermakov; A V Rodina; V V Fomin; N A Mukhin
Journal:  Ter Arkh       Date:  2012       Impact factor: 0.467

7.  Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.

Authors:  Nathalie C Leite; Cristiane A Villela-Nogueira; Vera L N Pannain; Adriana C Bottino; Guilherme F M Rezende; Claudia R L Cardoso; Gil F Salles
Journal:  Liver Int       Date:  2011-02-20       Impact factor: 5.828

8.  Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study.

Authors:  Juha Koskinen; Costan G Magnussen; Mika Kähönen; Britt-Marie Loo; Jukka Marniemi; Antti Jula; Liisa A Saarikoski; Risto Huupponen; Jorma S A Viikari; Olli T Raitakari; Markus Juonala
Journal:  Ann Med       Date:  2011-01-24       Impact factor: 4.709

Review 9.  Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes.

Authors:  Mary L Brandt; Carroll M Harmon; Michael A Helmrath; Thomas H Inge; Siripoom V McKay; Marc P Michalsky
Journal:  Nat Rev Endocrinol       Date:  2010-09-14       Impact factor: 43.330

10.  Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation.

Authors:  Leyla Akın; Selim Kurtoglu; Ali Yikilmaz; Mustafa Kendirci; Ferhan Elmalı; Mümtaz Mazicioglu
Journal:  Acta Paediatr       Date:  2012-12-29       Impact factor: 2.299

View more
  46 in total

1.  Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.

Authors:  Radojica V Stolic; Goran Z Trajkovic; Mirjana M Kostic; Sasa R Sovtic; Andrijana M Odalovic; Biljana D Krdzic; Maja V Sipic; Snezana Lazic; Zorica N Sojevic-Timotijevic
Journal:  Int Urol Nephrol       Date:  2016-02-23       Impact factor: 2.370

2.  Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.

Authors:  Saumya Jayakumar; Stephen A Harrison; Rohit Loomba
Journal:  Curr Hepatol Rep       Date:  2016-04-21

Review 3.  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial.

Authors:  Farzad Shidfar; Seyedeh Neda Mousavi; Hamid Lorvand Amiri; Shahram Agah; Sharieh Hoseini; Seyed Javad Hajimiresmail
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 5.  Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Akiko Sakasai-Sakai; Takanobu Takata; Tadashi Ueda; Mikihiro Tsutsumi; Hideyuki Hyogo; Sho-Ichi Yamagishi
Journal:  World J Hepatol       Date:  2014-12-27

6.  The effects of high fructose fruits and honey on the serum level of metabolic factors and nonalcoholic fatty liver disease.

Authors:  Fatemeh Sadeghi; Sasan Amanat; Mohammad Bakhtiari; Hadis Asadimehr; Mohammad Ali Okhovat; Masood Hosseinzadeh; Seyed Mohammad Mazloomi; Maryam Gholamalizadeh; Saeid Doaei
Journal:  J Diabetes Metab Disord       Date:  2021-10-28

7.  [Congxin Lunzhi Fang improves aortic atherosclerosis and regulates ACE2 expression in ApoE-/- mice].

Authors:  Y Gu; J Jiang; Y Zhang; Y Chen; Y Chen; W Jiang; Z Huang; F Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-11-20

8.  Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.

Authors:  María José Morlán-Coarasa; María Teresa Arias-Loste; Víctor Ortiz-García de la Foz; Obdulia Martínez-García; Carmen Alonso-Martín; Javier Crespo; Manuel Romero-Gómez; Emilio Fábrega; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2016-09-12       Impact factor: 4.530

9.  Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers.

Authors:  Nasrin Sharifi; Reza Amani; Eskandar Hajiani; Bahman Cheraghian
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-24

Review 10.  Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy.

Authors:  Qing-Qing Zhang; Lun-Gen Lu
Journal:  J Clin Transl Hepatol       Date:  2015-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.